Phenotyping common variable immunodeficiency by immune dysregulation at diagnosis: a descriptive comparison of baseline clinical and laboratory findings

Common variable immunodeficiency (CVID) is a heterogeneous antibody deficiency associated with infectious and noninfectious complications. Infection history guides clinical assessment, but its relationship with routine immunological markers and immune dysregulation at diagnosis remains unclear. The study aims to compare the clinical and immunological profiles at diagnosis between CVID patients with immune dysregulation and those without. Immunological markers independently associated with immune dysregulation were further evaluated. At diagnosis, 34 patients (40%) were identified as CVID-ID ( Immune Dysregulation) (+). Based on infection related components of the adult ESID warning signs, the annual frequency of clinically significant treatment requiring infectious episodes was significantly lower in the CVID-ID(+) group than in the CVID-ID(-) group (median 0 vs. 5 episodes; p < 0.001). Minor symptomatic mucosal/ upper respiratory tract infections events were more frequent in the CVID-ID(+) group than in the CVID-ID(-) group (23/34 [67.6%] vs. 22/51 [43.1%], p = 0.027). In multivariable analysis, reduced percentages of switched memory B-cells (SMBC) (OR: 0.56, 95% CI: 0.35–0.88; p = 0.012), lower CD4⁺ T-cell percentages (OR: 0.92, 95% CI: 0.88–0.97; p = 0.001), and lower serum IgA levels (OR: 0.27, 95% CI: 0.09–0.82; p = 0.020) were independently associated with the immune dysregulation phenotype. Lower SMBC percentages, CD4⁺ T-cell proportions, and serum IgA levels were associated with the CVID-ID(+) phenotype at diagnosis. Although these patients had fewer clinically significant treatment-requiring infections within the infection related components of the adult ESID warning signs, infection-centered measures alone may not fully capture the diagnostic profile of patients presenting with immune dysregulation. These findings remain hypothesis generating.

Authors

Institutions

Publication Details

Journal
BMC Immunology
Published
2026-11-19
DOI
https://doi.org/10.1186/s12865-026-00932-7
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Phenotyping common variable immunodeficiency by immune dysregulation at diagnosis: a descriptive comparison of baseline clinical and laboratory findings

Recep Evcen, Tuğba Önalan, Ümmügülsüm Yılmaz Ergün, Mehmet Kılınç et al.
1 links
BMC Immunology
Immunodeficiency and Autoimmune Disorders
article

Phenotyping common variable immunodeficiency by immune dysregulation at diagnosis: a descriptive comparison of baseline clinical and laboratory findings

Recep Evcen, Tuğba Önalan, Ümmügülsüm Yılmaz Ergün, Mehmet Kılınç, Şevket Arslan, Fatma Arzu Akkuş, Fatih Çölkesen, Selim Kahraman, Mehmet Emin Gerek, Filiz Sadi Aykan
article en

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous antibody deficiency associated with infectious and noninfectious complications. Infection history guides clinical assessment, but its relationship with routine immunological markers and immune dysregulation at diagnosis remains unclear. The study aims to compare the clinical and immunological profiles at diagnosis between CVID patients with immune dysregulation and those without. Immunological markers independently associated with immune dysregulation were further evaluated. At diagnosis, 34 patients (40%) were identified as CVID-ID ( Immune Dysregulation) (+). Based on infection related components of the adult ESID warning signs, the annual frequency of clinically significant treatment requiring infectious episodes was significantly lower in the CVID-ID(+) group than in the CVID-ID(-) group (median 0 vs. 5 episodes; p < 0.001). Minor symptomatic mucosal/ upper respiratory tract infections events were more frequent in the CVID-ID(+) group than in the CVID-ID(-) group (23/34 [67.6%] vs. 22/51 [43.1%], p = 0.027). In multivariable analysis, reduced percentages of switched memory B-cells (SMBC) (OR: 0.56, 95% CI: 0.35–0.88; p = 0.012), lower CD4⁺ T-cell percentages (OR: 0.92, 95% CI: 0.88–0.97; p = 0.001), and lower serum IgA levels (OR: 0.27, 95% CI: 0.09–0.82; p = 0.020) were independently associated with the immune dysregulation phenotype. Lower SMBC percentages, CD4⁺ T-cell proportions, and serum IgA levels were associated with the CVID-ID(+) phenotype at diagnosis. Although these patients had fewer clinically significant treatment-requiring infections within the infection related components of the adult ESID warning signs, infection-centered measures alone may not fully capture the diagnostic profile of patients presenting with immune dysregulation. These findings remain hypothesis generating.

BMC Immunology
Necmettin Erbakan University (TR), Samsun University (TR), Konya Eğitim ve Araştırma Hastanesi (TR), Sağlık Bilimleri Üniversitesi (TR), Konya City Hospital (TR), Gülhane Eğitim ve Araştırma Hastanesi (TR), SBÜ Beyhekim Training and Research Hospital (TR), Eskişehir Osmangazi University (TR)
Good health and well-being
Immunodeficiency and Autoimmune Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon